0001019687-15-004483.txt : 20151211 0001019687-15-004483.hdr.sgml : 20151211 20151211160553 ACCESSION NUMBER: 0001019687-15-004483 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20151027 FILED AS OF DATE: 20151211 DATE AS OF CHANGE: 20151211 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Medytox Solutions, Inc. CENTRAL INDEX KEY: 0001374536 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-TESTING LABORATORIES [8734] IRS NUMBER: 900902741 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 400 S. AUSTRALIAN AVENUE, SUITE 800 CITY: WEST PALM BEACH STATE: FL ZIP: 33401 BUSINESS PHONE: 561-855-1626 MAIL ADDRESS: STREET 1: 400 S. AUSTRALIAN AVENUE, SUITE 800 CITY: WEST PALM BEACH STATE: FL ZIP: 33401 FORMER COMPANY: FORMER CONFORMED NAME: CASINO PLAYERS, INC. DATE OF NAME CHANGE: 20060905 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Diamantis Christopher Eric CENTRAL INDEX KEY: 0001578723 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-54346 FILM NUMBER: 151283329 MAIL ADDRESS: STREET 1: 400 SOUTH AUSTRALIAN AVENUE STREET 2: 8TH FLOOR CITY: WEST PALM BEACH STATE: FL ZIP: 33401 4 1 dimantis_frm4.xml FORM 4 X0306 4 2015-10-27 1 0001374536 Medytox Solutions, Inc. MMMS 0001578723 Diamantis Christopher Eric 400 S. AUSTRALIAN AVENUE, 8TH FLOOR WEST PALM BEACH FL 33401 1 0 0 0 Common Stock 2015-10-27 4 P 0 100000 1.00 A 850000 D Common Stock 2015-11-02 4 D 0 850000 D 0 D Options to Purchase Common Stock 5.00 2015-11-02 4 D 0 100000 A 2013-04-19 2017-04-19 Common Stock 100000 0 D Options to Purchase Common Stock 5.00 2015-11-02 4 D 0 50000 A 2014-04-19 2017-04-19 Common Stock 50000 0 D Options to Purchase Common Stock 2.50 2015-11-02 4 D 0 100000 A 2013-04-19 2017-04-19 Common Stock 100000 0 D Options to Purchase Common Stock 2.50 2015-11-02 4 D 0 50000 A 2014-04-19 2017-04-19 Common Stock 50000 0 D Disposed of pursuant to merger agreement among Medytox Solutions, Inc. ("Medytox"), CollabRx Merger Sub, Inc. ("Merger Sub"), and Rennova Health, Inc. ("Rennova") (f/k/a/ CollabRx, Inc.) in exchange for 348,193 shares of Rennova common stock. Cancelled pursuant to merger agreement and related transactions between Medytox and Rennova. Disposed of pursuant to the merger agreement among Medytox, Merger Sub and Rennova. The options were assumed by Rennova in the merger and replaced with options to purchase 40,963 shares of Rennova common stock at an exercise price of $6.11 per share. Disposed of pursuant to the merger agreement among Medytox, Merger Sub and Rennova. The options were assumed by Rennova in the merger and replaced with options to purchase 20,481 shares of Rennova common stock at an exercise price of $6.11 per share. /s/ Christopher Eric Diamantis 2015-12-11